In a study of diet and early breast cancer, blood plasma copper has be
en analyzed by Proton Induced X-ray Emission analysis as both total co
pper (P-Cu) and that ultrafiltrable from plasma (P-edu-Cu) through mem
branes with a cut-off at molecular mass 10,000 after equilibration wit
h disodium ethylene diamine tetraacetic acid (EDTA) at 4 degrees C. Ce
ruloplasmin (P-cer) was also measured using nephelometry of anticerulo
plasmin monoclonal antibody-ceruloplasmin complexes. Dietary copper in
take per day (D-Cu) was assessed over a five-day dietary record period
and calculated from dietary components using a computer program. P-ed
u-Cu correlated significantly with both D-Cu and ceruloplasmin while P
-Cu correlated only with ceruloplasmin. Further, ceruloplasmin did not
significantly correlate to D-Cu. Hence, P-edu-Cu better reflects copp
er status than do P-cer or P-Cu as it relates to both the major copper
enzyme in plasma and to daily copper intake. This may be important in
drawing conclusions about the significance of copper in disease state
s where copper fractions other than ceruloplasmin may be most importan
t owing, for example, to oxidative properties. Categorization as cance
r or normal, by copper parameters (D-Cu, P-edu-Cu, P-Cu, P-cer), was s
tudied in multiple correlation. In particular, the ratio P-cer/P-Cu an
d the ratio P-edu-Cu/D-Cu were significantly related to disease. Irres
pective of age (pre- and post-menopausal), highly significant differen
ces between normals and early stage breast cancer patients were seen w
ith p < 0.0001 to p < 0.01. The precise role played by plasma and diet
ary copper fractions deserves continued attention in view of the prese
nt and earlier results in cancer studies.